{"id":27876,"date":"2025-01-31T13:30:00","date_gmt":"2025-01-31T12:30:00","guid":{"rendered":"https:\/\/qlinea.com\/mfn_news\/vikas-gupta-pharmd-fidsa-joins-q-linea-as-senior-director-of-clinical-affairs\/"},"modified":"2025-01-31T13:56:07","modified_gmt":"2025-01-31T12:56:07","slug":"vikas-gupta-pharmd-fidsa-joins-q-linea-as-senior-director-of-clinical-affairs","status":"publish","type":"mfn_news","link":"https:\/\/qlinea.com\/us\/mfn_news\/vikas-gupta-pharmd-fidsa-joins-q-linea-as-senior-director-of-clinical-affairs\/","title":{"rendered":"Vikas Gupta, PharmD, FIDSA joins Q-linea as Senior Director of Clinical Affairs"},"content":{"rendered":"
\n

Q-linea AB (publ) (OMX: QLINEA) today announces that Dr. Vikas Gupta, a Fellow of the Infectious Diseases Society of America, joins Q-linea effective February 1, 2025.<\/strong><\/p>\n<\/div>\n

\n

Dr. Gupta brings decades of experience in the industry, including eight years at Becton, Dickinson and Company and dozens of publications. His recent work regarding antimicrobial resistance rates in oncology patients, as well as the impacts of delayed time to antibiotic therapy on mortality and length of stay for bacteremia patients, is especially relevant to Q-linea’s mission.<\/p>\n

Dr. Gupta is a seasoned clinical pharmacist with experience in patient care and developing and implementing clinical programs in academic and non-academic settings.  He earned his Doctor of Pharmacy degree from the University of Illinois, College of Pharmacy and completed his residency in Clinical Pharmacy Practice at the Hospital of the University of Pennsylvania.<\/p>\n<\/div>\n

\n

For more information, please contact:<\/strong><\/p>\n

\n

Stuart Gander, President & CEO, Q-linea
Stuart.Gander@qlinea.com<\/a>
+1 857 409 7463<\/p>\n

Christer Samuelsson, CFO \/IR, Q-linea AB
Christer.Samuelsson@qlinea.com<\/a>
+46 (0) 70-600 15 20<\/p>\n<\/div>\n

\n

About Q-linea<\/strong><\/p>\n

\n

Q-linea’s rapid AST system, ASTar®, accelerates and simplifies the time-sensitive workflows faced during the treatment of patients with bloodstream infections and sepsis. Hospitals use ASTar to vastly reduce the time to optimal antimicrobial therapies and ensure that patients receive the correct treatments sooner — when time matters most. We are helping to create sustainable healthcare, now and in the future, and safeguard the effectiveness of antibiotics for generations to come.
Q-linea is headquartered in Uppsala, Sweden and has regional offices in Italy and the USA, with partnerships worldwide.
ASTar Instrument and ASTar BC G- Consumable kit are CE-IVD marked and FDA 510(k) cleared. For more information, please visit www.qlinea.com<\/p>\n<\/div>\n

\n

Attachments<\/strong><\/p>\n

\n

Vikas Gupta, PharmD, FIDSA joins Q-linea as Senior Director of Clinical Affairs<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Q-linea AB (publ) (OMX: QLINEA) today announces that Dr. Vikas Gupta, a Fellow of the Infectious Diseases Society of America, joins Q-linea effective February 1,…<\/p>\n","protected":false},"template":"","class_list":["post-27876","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci-us","mfn-news-tag-mfn-lang-en-us","mfn-news-tag-mfn-type-ir-us","mfn-news-tag-mfn-us","mfn-news-tag-mfn-ci-other-us"],"acf":[],"_links":{"self":[{"href":"https:\/\/qlinea.com\/us\/wp-json\/wp\/v2\/mfn_news\/27876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/qlinea.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/qlinea.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/qlinea.com\/us\/wp-json\/wp\/v2\/media?parent=27876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}